Pharmaceutical Company Mylan to Pay $20.3 Million for Underpaying Rebates on Epipens for Masshealth Members
BOSTON - Pharmaceutical company Mylan will pay a total of $20.3 million to the Massachusetts Medicaid program (MassHealth) to resolve allegations that it knowingly underpaid rebates owed to the Medicaid program for EpiPens dispensed to MassHealth members, Attorney General Maura Healey announced today.
- Date:October 3, 2017
- Agency:Massachusetts Attorney General
- State Enforcement Agencies